KUALA LUMPUR: Hong Seng Consolidated Bhd’s wholly-owned subsidiary, HS Bio Sdn Bhd( HS Bio) has entered into a share sale agreement to acquire a 51 per cent stake in the COVID-19 antibody test kit distributor RZAC Immunesafe Sdn Bhd for RM20 million.In a statement today, Hong Seng said the total purchase consideration of RM20 million comprises a cash payment of RM2 million and the issuance of 37, 800 new ordinary shares in HS Bio worth RM18 million. RZAC is currently the sole distributor of the
综合
星报-商业
1
2021-10-02 00:00:00.0